WEST BRIDGEWATER, Mass. -- Pressure BioSciences Inc. has installed a Pressure Cycling Technology Sample Preparation System at the USDA ARS Root Disease and Biological Control Research Unit in Pullman, Wash.



This follows the signing of a three-year lease agreement for the PCT SPS. PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions.



The USDA-ARS is expected to use the PCT SPS for a number of research applications, primarily in the detection and quantification of pathogenic microbes in plant roots and in soil. If successful, these studies could result in the development of improved management of soilborne pathogens for dry-land crops, such as wheat and canola, and in the development of crop plants with enhanced pathogen tolerance.



Richard T. Schumacher, Founder, President, and CEO of Pressure BioSciences, said: "Over the past year, we have installed PCT Sample Preparation Systems at a number of important government agencies, including the FBI, the FDA, and the NIH. We are pleased to add the USDA to this prestigious list of PCT SPS users, and look forward to working with our colleagues at the USDA-ARS as they apply Pressure Cycling Technology to new and exciting areas of agricultural science."



Under the terms of the lease agreement, the USDA-ARS will pay PBI a monthly fee, is expected to purchase a minimum number of processing containers (PULSE Tubes) each month, and has the right to purchase the instrument at any time during the three year lease term.

Pressure BioSciences Inc. is a publicly traded, early-stage company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 U.S. and 5 foreign patents covering multiple applications of PCT in the life sciences field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of enzymes, immunodiagnostics, and protein purification.

SOURCE: Pressure BioSciences Inc. via Business Wire.